Newsroom | 30624 results

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, announced that beginning October 1, 2026, eligible Anthem® Blue Cross® and Blue Shield® members will be the first in the United States to receive insurance coverage under a medical policy for the PrecivityAD2® blood test. This policy expands patient access to an innovative blood-based diagnostic test that helps health care professionals evaluate adults exp...

LIBERTYVILLE, Ill.--(BUSINESS WIRE)--Sumitomo Biorational Company LLC today announced the appointment of Remy Lyczko as President of its AgroSolutions Division (ASD), effective July 1, 2026. In this role, Lyczko will lead the division responsible for developing innovative biorational and botanical technologies that help growers improve productivity while advancing more sustainable agricultural systems. Under his leadership, the division will continue to expand solutions that support modern farm...

ROCKVILLE, Md.--(BUSINESS WIRE)--The Maryland Tech Council (MTC), the largest technology and life sciences trade association in the state, today announced the election of new members to its Board of Directors. Bringing decades of expertise across technology, life sciences, and related industries, the directors will help guide MTC’s strategy and planning for the 2-year term. "We are excited to collaborate with this dynamic group of new board members," said Kelly Schulz, CEO of the Maryland Tech...

LA JOLLA, Calif.--(BUSINESS WIRE)--Arialys Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of ANRE...

SAN JOSE, Calif.--(BUSINESS WIRE)--President & CEO of Takara Bio USA Carol Lou announces she is retiring after 20 years of service, with Andrew Farmer as her successor....

SAN DIEGO--(BUSINESS WIRE)--Auxilium Biotechnologies successfully bioprinted kidney and liver tissues aboard the International Space Station (ISS) for the first time in history....

ST. LOUIS--(BUSINESS WIRE)--Confluence Genetics today announced the launch of Cas-CLEAR™, Collaterally Enhanced Activated Ribonuclease, a new CRISPR technology platform for the treatment of cancers carrying defined genetic signatures, with lead programs in development for hepatocellular carcinoma (HCC). Unlike gene editing CRISPR systems that cut and modify DNA at a single site, Cas-CLEAR uses Cas12a2 nucleases to recognize cancer-specific genetic signatures and trigger broad collateral cleavag...

VILLEJUIF, France--(BUSINESS WIRE)--Orano Med has appointed Caroline Germa, Jean-Pierre Bizzari and Philippe Archinard as independent members of the Governing Board....

VILLEJUIF, France--(BUSINESS WIRE)--Orano Med, filiale du groupe Orano spécialisée en médecine nucléaire, annonce la nomination de Caroline Germa, Jean-Pierre Bizzari et Philippe Archinard en qualité de membres indépendants du Conseil de gouvernance dédié aux activités de biotechnologie de la filiale. Ils exerceront leurs fonctions aux côtés de Fabrice Chouraqui, membre du Conseil de gouvernance depuis 2022, et dont le mandat se poursuit. Ces trois nouveaux membres apportent au Conseil une expe...

SAN FRANCISCO--(BUSINESS WIRE)--Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, and Modality.AI, a leader in AI-enabled multimodal clinical assessments, today announced a collaboration to explore how molecular biomarkers and objective digital assessments can be combined to improve the characterization of central nervous system (CNS) disorders. The collaboration brings together Amprion's expertise in detecting disease-specific misfo...